Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Julie Bulman

Interventional Radiology · BIDMC

View

Dr. Ram Vaidhyanath

Neuroradiology

View

Dr. Monica Sheth

Breast Imaging · NYU Langone

View

Dr. Victoria Chernyak

Abdominal Imaging · CUIMC

View

Dr. Judith Gadde

Neuroradiology · Lurie Children's Hospital

View

Dr. Wende Gibbs

Neuroradiology · Barrow Neurological Institute

View

Dr. Laura Hayes

Peds Radiology · Children's Healthcare of Atlanta

View

Dr. Amy Patel

Breast Imaging · UKHS

View

Dr. Erin Alaia

MSK Radiology · NYU Langone

View

Dr. Lincoln Berland

Abdominal Imaging · UAB

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Can Qualitative Subfield Analysis on High-Resolution MRI Predict Histopathologic Subtypes of Hippocampal Sclerosis?

    Jun 3, 2026DOI: 10.3174/ajnr.a9128Journal ArticleAJNR

    Written by: Smily SharmaAditya AjithRajalakshmi PoyuranAshalatha RadhakrishnanChandrasekharan KesavadasGeorge C VilanilamBejoy Thomas

    Find these authors on Roon

    GV
    Dr. George Vilanilam
    Interventional Neuroradiology · UT Southwestern

    Summary

    BACKGROUND AND PURPOSE: The International League Against Epilepsy classifies hippocampal sclerosis (HS) on the basis of the degree of neuronal loss affecting hippocampal subfields. Due to the differences in clinical presentation and postoperative outcomes, preoperative prediction of HS subtypes by MRI can aid in surgical decision-making. The current study aims to evaluate the utility of preoperative high-resolution MRI in this prediction.MATERIALS AND METHODS: With institutional ethics committee approval, we conducted a retrospective observational study in a single tertiary referral center. Consecutive histopathology-proved cases of unilateral mesial temporal sclerosis from January 2018 to June 2023 were included if the patients also had a preoperative MRI study on a 3T scanner performed with a high-resolution epilepsy protocol. Two neuroradiologists, blinded to the histopathologic results, independently performed MRI grading by assessing volume loss in the hippocampal subfields on a high-resolution 2D coronal T2-weighted sequence. The discrepancies were resolved by a senior neuroradiologist. An agreement was sought between the MRI grading and the histopathologic grading of HS.RESULTS: A total of 106 patients (57 males) were included with a mean age of 23.8 years. Type 1 HS was the most common subtype on both MRI (n = 71) and histopathology (n = 89). MRI detected no HS/gliosis only (GO) subtype of HS with 72.7% (95% CI, 43.4%-90.3%) sensitivity and 97.9% (95% CI, 92.7%-99.4%) specificity, and type 1 HS with 75.3% (95% CI, 65.4%-83.1%) sensitivity and 76.5% (95% CI, 52.7%-90.4%) specificity. Despite good interobserver agreement (Cohen κ, 0.770; P < .01), MRI showed only a fair agreement with histopathology (Cohen κ, 0.328; P < .01) in subclassifying HS. For individual HS subtypes, MRI showed good agreement in predicting the GO subtype (Cohen κ, 0.736; P <.01) and fair agreement (Cohen κ, 0.362; P < .01) in predicting HS type 1.CONCLUSIONS: Hippocampal subfield analysis is feasible with high-resolution 3T MRI, with good interobserver agreement. MRI grading based on a qualitative assessment of volume loss in hippocampal subfields can predict the GO subtype with good agreement compared with histopathology. However, differentiation of HS types 1, 2, and 3 subtypes from each other may not be feasible preoperatively with the current clinical 3T MRI protocols.
    GVDr. George Vilanilam

    Dr. George Vilanilam

    Radiology · Interventional Neuroradiology
    The University of Texas Southwestern Medical Center
    georgevilanilam
    Dallas, TX, USA